Randomized Placebo-Controlled Trial of Reloxaliase in Enteric Hyperoxaluria
{{output}}
BACKGROUND: Enteric hyperoxaluria is caused by increased intestinal oxalate absorption and can lead to kidney stones, chronic kidney disease, and kidney failure. Reloxaliase is an orally administered recombinant enzyme that degrades oxalate along the gastroint... ...